Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing <i>Klebsiella pneumoniae</i>

• Main Authors: Lei Zha (Author), Xiang Li (Author), Zhichu Ren (Author), Dayan Zhang (Author), Yi Zou (Author), Lingling Pan (Author), Shirong Li (Author), Shanghua Chen (Author), Boris Tefsen (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The effectiveness of piperacillin/tazobactam for managing nosocomial pneumonia caused by extended-spectrum β-lactamase (ESBL)-producing <i>Enterobacteriaceae</i> is unknown. To answer this question, we conducted a retrospective cohort study in two tertiary teaching hospitals of patients...